Table 3.
Chemical properties and biological activity of photosensitizers used in vitro assays for inactivation of bacterial biofilms of Gram-negative bacteria
# | Structure | Biofilm strain | Results |
---|---|---|---|
1 |
5-ALA: protoporphyrin IX precursor (PS9a) Charge: 0 MW = 131 Da |
E. coli (clinical isolate) and P. aeruginosa ATCC 27853 [138] |
Outcome: 0 and 3 log CFU reduction, respectively [PS] = 40 mM ALA Light dose: 142 J/cm2 (Tungsten Halogen lamps 500 W) |
2 | K. pneumoniae ATCC 700603 [149] |
Outcome: 3.1 log CFU reduction [PS] = 10 mM ALA Light dose: 360 J/cm2 (150 W xenon lamp λ = 400–780 nm) |
|
3 |
MAL: protoporphyrin IX precursor (PS9b) Charge: 0 MW = 145 Da |
K. pneumoniae ATCC 700603 [149] |
Outcome: 4.3 log CFU reduction [PS] = 10 mM MAL Light dose: 360 J/cm2 (150 W xenon lamp λ = 400–780 nm) |
4 |
Porphyrin Mixture FORM (PS3) Charge: + 1 to + 4 MW = 679 to 900 Da |
Bioluminescent E. coli [131] |
Outcome: ~ 7 log CFU reduction [PS] = 1.0 µM (in combination with 100 mM KI) Light dose: 9 J/cm2 (white fluorescent lamp λ = 380–700 nm) |
5 |
PS4 (in polymeric micelles of Pluronic F-127) Charge: + 4 MW = 1384 Da |
E. coli C600 [132] |
Outcome: 0.5 log CFU reduction [PS] = 10 µM Light dose: 128 J/cm2 (500 W halogen lamp with filter λ = 420–1000 nm) |
6 |
TAPP (PS5) Charge: 0 to +4 (pH dependent) MW = 1019 Da |
P. aeruginosa (clinical isolate) [133] |
Outcome: 3 log CFU reduction [PS] = 30 µM Light dose: 180 J/cm2 (Tungsten Halogen lamps 500 W) |
7 |
MgPc-octamorph (PS10) Charge: + 8 MW = 1690 Da |
P. aeruginosa K1 [139] |
Outcome: 2.4 log CFU reduction [PS] = 1 mM Light dose: 1.9 J/cm2 (visible light) |
8 |
ZnPc_iPyr4 (PS22) Charge: + 8 MW = 1123 Da |
Bioluminescent E. coli Top10 [150] |
Outcome: 2 log CFU reduction [PS] = 40 µM Light dose: 540 J/cm2 (Halogen/quartz 250 W lamp) |
9 |
ZnPc_iPyr8 (PS23) Charge: + 16 MW = 1667 Da |
Bioluminescent E. coli Top10 [150] |
Outcome: 2 log CFU reduction [PS] = 40 µM Light dose: 540 J/cm2 (Halogen/quartz 250 W lamp) |
10 | Curcumin (PS14) + Phycocyanin (PS15) (in chitosan nanoparticles) | P. aeruginosa KY770785.1 [145] |
Outcome: 0.9 log CFU reduction [PS] = : 100 µg/ml Light dose: 10 min with 5 W LED lamp |
11 |
Curcumin (PS14) (Imobilized in endotracheal tubes) |
E. coli ATCC 25922 and P. aeruginosa ATCC 14502 [144] |
Outcome: 0.7 log CFU reduction [PS] = 0.5% w/w Light dose: 50 J/cm2 (LED λ = 450 nm) |
12 |
Riboflavin (PS13) Charge: 0 MW = 376 Da |
MDR E. coli (clinical isolate) [142] |
Outcome: 0.2 log CFU reduction [PS] = 50 µM Light dose: n.a. (LED λ = 450 nm; 40 W/cm2) |
13 |
Rose bengal (conjugate with carbon nanotubules) (PS24) Charge: 0/− 1 MW = n.a |
E. coli MCC 2412 [151] |
Outcome: 0.4 log CFU reduction [PS] = 50 µg/ml Light dose: 1674 J/cm2 (λ = 532 nm) |
14 |
SAPYR (PS16) Charge: + 1 MW = 272 Da |
E. coli ATCC 25922 [146] |
Outcome: 2.9 log CFU reduction [PS] = 500 µM Light dose: 30 J/cm2 (gas-discharge lamp λ = 380–600 nm) |
15 |
SAPYR-PN-05 (PS17) Charge: + 1 MW = 407 Da |
E. coli ATCC 25922 [146] |
Outcome: 3.5 log CFU reduction [PS] = 500 µM Light dose: 30 J/cm2 (gas-discharge lamp λ = 380–600 nm) |
16 |
Methylene blue (PS18) Charge: + 1 MW = 284 Da |
E. coli ATCC 25922 [152] |
Outcome: 3 log CFU reduction [PS] = 31 µM Light dose: 18 J/cm2 (LEDs 625 ± 25 nm) |
17 | P. aeruginosa ATCC 27853 [147] |
Outcome: 6 log CFU reduction [PS] = 2.5 mM Light dose: 18 J/cm2 (LEDs λ = 625 ± 10 nm) |
|
18 |
Methylene blue (PS18) (in dextran capped gold nanoparticles) Charge: + 1 MW = 284 Da |
K. pneumoniae (clinical isolate) [153] |
Outcome: 7 log CFU reduction [PS] = 70 µM Light dose: 40 J/cm2 (laser λ = 660 nm) |
19 |
MB-PMX (PS25) Charge: + 1 MW = 1723 Da |
E. coli ATCC 25922 [154] |
Outcome: 7 log CFU reduction [PS] = 50 µM Light dose: 288 J/cm2 (LED λ = 625 nm) |